alpha-Methyldopa
| Code | Size | Price |
|---|
| TAR-T25054-5mg | 5mg | £930.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25054-50mg | 50mg | £1,821.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25054-100mg | 100mg | £2,319.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
alpha-Methyldopa is an agonist of alpha-2 adrenergic. It has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive compound.
CAS:
555-29-3
Formula:
C10H13NO4
Molecular Weight:
211.22
Purity:
0.98
SMILES:
NC(CC1=CC=C(O)C(O)=C1)(C)C(O)=O
References
1. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501026/ PubMed PMID: 30000085.
2. Schneider F, Erisson L, Beygi H, Bradbury M, Cohen-Barak O, Grachev ID, Guzy S, Loupe PS, Levi M, McDonald M, Savola JM, Papapetropoulos S, Tracewell WG, Velinova M, Spiegelstein O. Pharmacokinetics, Metabolism and Safety of Deuterated L-DOPA (SD-1077)/Carbidopa (CD) Compared to L-DOPA/CD following single oral dose administration in Healthy Subjects. Br J Clin Pharmacol. 2018 Jun 29. doi: 10.1111/bcp.13702. [Epub ahead of print] PubMed PMID: 29959802.
3. Bortolotto MR, Francisco RPV, Zugaib M. Resistant Hypertension in Pregnancy: How to Manage? Curr Hypertens Rep. 2018 Jun 11;20(8):63. doi: 10.1007/s11906-018-0865-z. Review. PubMed PMID: 29892919.
4. Zakiyah N, Ter Heijne LF, Bos JH, Hak E, Postma MJ, Schuiling-Veninga CCM. Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study. BMC Pregnancy Childbirth. 2018 May 29;18(1):187. doi: 10.1186/s12884-018-1825-y. PubMed PMID: 29843629; PubMed Central PMCID: PMC5975401.